FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia

Annals of Hematology

Volumn 84, Issue 12, 2005, Pages 792-795

  Specchia, G ^a   Pastore, D ^a   Carluccio, P ^a   Liso, A ^a   Mestice, A ^a   Rizzi, R ^a   Ciuffreda, L ^a   Pietrantuono, G ^a   Liso, V ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Acute lymphoblastic leukemia; FLAG IDA; Refractory; Relapsed

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARAGINASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; PREDNISONE; THIOTEPA; THYMOCYTE ANTIBODY; VINCRISTINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASIA; ARTICLE; BLEEDING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DONOR; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SIDE EFFECT; SKIN DISEASE; THROMBOCYTE COUNT; VOMITING; WHOLE BODY RADIATION;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IDARUBICIN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKOCYTE COUNT; LIVER; MALE; MIDDLE AGED; MUCOSITIS; PLATELET COUNT; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIDARABINE;

EID: 28944449600     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1090-9     Document Type: Article

References (18)

1. Atra A, Gerrard M, Hobson R, Imeson J, Hann I, Pinkerton C (2001) Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/ 9002 protocols. Br J Haematol 112:965-968 10.1046/ j.1365-2141.2001.02647.x
2. Camera A, Annino L, Chiurazzi F, Fazi P, Cascavilla N, Fabbiano F, Marmont F, Di Raimondo F, Recchia A, Vignetti M, Rotoli B, Mandelli F (2004) GIMEMA ALL-Rescue 97: A salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia. Haematologica 89:145-153 15003889
3. Estey E, Thall P, Andreff M, Beran M, Kantarjian H, O'Brien S, Escudier S, Robertson LE, Koller C, Kornblau S et al (1994) Use of granulocyte colony-stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodisplastic syndromes: Comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J Clin Oncol 12:671-678 7512125
4. Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A, Henke M, Hiddemann W, Haas R, Kuse R et al (1992) Treatment of relapsed or refractory adult acute lymphocytic leukemia. Cancer 69:709-716 1730121
5. Gandhi V, Estey E, Keating M, Plunkett W (1993) Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J Clin Oncol 11:116-124 8418222
6. Giona F, Testi AM, Annino L, Amadori S, Arcese W, Camera A, Di Montezemolo LC, Ladogana S, Liso V, Meloni G et al (1994) Treatment of primary refractory and relapsed acute lymphoblastic leukemia in children and adults: The GIMEMA-AIEOP experience. Br J Haematol 86:55-61 8011548
7. Keating M, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H (1998) Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 92:1165-1171 9694704
8. Koller C, Kanatrjian H, Thomas D, O'Brien S, Rios M, Kornblau S, Murphy S, Keating M (1997) The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia 11:2039-2044 10.1038/ sj.leu.2400861
9. Martino R, Bellido M, Brunet S, Sureda A, Peyret M, Guardia R, Altes A, Domingo-Albos A, Sierra J (1998) Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia. Bone Marrow Transplant 21:1023-1027 10.1038/sj.bmt.1701221
10. Martino R, Bellido M, Brunet S, Altes A, Sureda A, Guardia R, Aventin A, Nomdedeu J, Albos A, Sierra J (1999) Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial. Haematologica 84:505-510 10366793
11. Michelutti A, Michieli M, Damiani D, Melli C, Ermacora A, Grimaz S, Candoni A, Russo D, Fanin R, Baccarani M (1997) Effect of fludarabine and arabinosylcytosine on multidrug-resistance cells. Haematologica 82:143-147 9175315
12. Montillo M, Tedeschi A, Centurioni R, Leoni P (1997) Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leuk Lymphoma 25:579-582 9250830
13. Pastore D, Specchia G, Carluccio P, Liso A, Mestice A, Rizzi R, Greco G, Buquicchio C, Liso V (2003) FLAG-IDA in the treatment of refractory/ relapsed acute myeloid leukemia: Single center experience. Ann Hematol 82:231-235 12707726
14. Rosen P, Rankin C, Head D, Boldt D, Luthardt F, Norwood T, Pugh R, Karenes C, Appelbaum (2000) A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. Leuk Res 24:183-187 10.1016/S0145-2126(99)00148-4
15. Suki S, Kantarjian H, Gandhi V, Estey E, O'Brien S, Bera M, Rios MB, Plunkett W, Keating M (1993) Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia. Cancer 72:2155-2160 8374873
16. Thomas D, Kantarjian H, Smith T, Koller C, Cortes J, O'Brien S, Giles F, Gajewski J, Pierce S, Keating M (1999) Primary refractory and relapsed adult acute lymphoblastic leukemia. Characteristics, treatment results and prognosis with salvage treatment. Cancer 86:1216-1230 10.1002/ (SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O
17. Weiss M, Drullinsky P, Maslak P, Schenberg D, Golde D (1998) A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia. Leukemia 12:865-868 10.1038/ sj.leu.2401058
18. World Health Organization 1979 A handbook for reporting results of cancer patients WHO Geneva